Purpose: To evaluate the Athena Multi-Lyte ANA TestSystem utilizesLuminex Corporation's MBA technology for the detection of antinuclearantibodies (ANA) andENA antibodies in the sera of patients with Sjogren's syndrome (SS). This evidence concerns the gene BTG3 and synovial sarcoma.